Open AccessT030 (0103) BENDAMUSTINE, GEMCITABINE, AND DEXAMETHASONE (BGD) CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IS EFFECTIVE TREATMENT FOR PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA (RHL) – RESULTS OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG) PILOT STUDY – PRE‐PLRG‐HL1 (BURGUND)
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547953.98381.b0
Subject(s) - gemcitabine , medicine , bendamustine , autologous stem cell transplantation , oncology , dexamethasone , chemotherapy , lymphoma , refractory (planetary science) , transplantation , hodgkin lymphoma , rituximab , biology , astrobiology